Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 913 to 922 of 922 entries
Sorted by: Best Match Show Resources per page
Ionized or Total Magnesium levels, what should we measure in critical ill patients?.

Translational medicine @ UniSa

Scarpati G, Baldassarre D, Oliva F, Pascale G, Piazza O.
PMID: 34447718
Transl Med UniSa. 2020 Oct 01;23:68-76. doi: 10.37825/2239-9747.1015. eCollection 2020 Sep.

Monitoring and measuring magnesium (Mg) values are essential to prevent the development of numerous complications in perioperative medicine and critically ill patients. Although previous studies suggest that measuring free ionized magnesium (iMg) is more useful for estimating Mg status,...

Cite
Scarpati G, Baldassarre D, Oliva F, et al. Ionized or Total Magnesium levels, what should we measure in critical ill patients?. Transl Med UniSa. 2020;23:68-76doi: 10.37825/2239-9747.1015.
Scarpati, G., Baldassarre, D., Oliva, F., Pascale, G., & Piazza, O. (2020). Ionized or Total Magnesium levels, what should we measure in critical ill patients?. Translational medicine @ UniSa, 2368-76. https://doi.org/10.37825/2239-9747.1015
Scarpati, G, et al. "Ionized or Total Magnesium levels, what should we measure in critical ill patients?." Translational medicine @ UniSa vol. 23 (2020): 68-76. doi: https://doi.org/10.37825/2239-9747.1015
Scarpati G, Baldassarre D, Oliva F, Pascale G, Piazza O. Ionized or Total Magnesium levels, what should we measure in critical ill patients?. Transl Med UniSa. 2020 Oct 01;23:68-76. doi: 10.37825/2239-9747.1015. eCollection 2020 Sep. PMID: 34447718; PMCID: PMC8370522.
Copy Download .nbib Format: NLM
Clinical impact of rare variants associated with inherited channelopathies: a 5-year update.

Human genetics

Sarquella-Brugada G, Fernandez-Falgueras A, Cesar S, Arbelo E, Coll M, Perez-Serra A, Puigmulé M, Iglesias A, Alcalde M, Vallverdú-Prats M, Fiol V, Ferrer-Costa C, Del Olmo B, Picó F, Lopez L, García-Alvarez A, Jordà P, Tiron de Llano C, Toro R, Grassi S, Oliva A, Brugada J, Brugada R, Campuzano O.
PMID: 34546463
Hum Genet. 2021 Sep 21; doi: 10.1007/s00439-021-02370-4. Epub 2021 Sep 21.

A proper interpretation of the pathogenicity of rare variants is crucial before clinical translation. Ongoing addition of new data may modify previous variant classifications; however, how often a reanalysis is necessary remains undefined. We aimed to extensively reanalyze rare...

Cite
Sarquella-Brugada G, Fernandez-Falgueras A, Cesar S, et al. Clinical impact of rare variants associated with inherited channelopathies: a 5-year update. Hum Genet. 2021;doi: 10.1007/s00439-021-02370-4.
Sarquella-Brugada, G., Fernandez-Falgueras, A., Cesar, S., Arbelo, E., Coll, M., Perez-Serra, A., Puigmulé, M., Iglesias, A., Alcalde, M., Vallverdú-Prats, M., Fiol, V., Ferrer-Costa, C., Del Olmo, B., Picó, F., Lopez, L., García-Alvarez, A., Jordà, P., Tiron de Llano, C., Toro, R., Grassi, S., Oliva, A., Brugada, J., Brugada, R., & Campuzano, O. (2021). Clinical impact of rare variants associated with inherited channelopathies: a 5-year update. Human genetics, . https://doi.org/10.1007/s00439-021-02370-4
Sarquella-Brugada, Georgia, et al. "Clinical impact of rare variants associated with inherited channelopathies: a 5-year update." Human genetics vol. (2021). doi: https://doi.org/10.1007/s00439-021-02370-4
Sarquella-Brugada G, Fernandez-Falgueras A, Cesar S, Arbelo E, Coll M, Perez-Serra A, Puigmulé M, Iglesias A, Alcalde M, Vallverdú-Prats M, Fiol V, Ferrer-Costa C, Del Olmo B, Picó F, Lopez L, García-Alvarez A, Jordà P, Tiron de Llano C, Toro R, Grassi S, Oliva A, Brugada J, Brugada R, Campuzano O. Clinical impact of rare variants associated with inherited channelopathies: a 5-year update. Hum Genet. 2021 Sep 21; doi: 10.1007/s00439-021-02370-4. Epub 2021 Sep 21. PMID: 34546463.
Copy Download .nbib Format: NLM
Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.

Hepatology (Baltimore, Md.)

Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, Ollivier-Hourmand I, Baiges A, Sutter O, Bouzbib C, Peron JM, Le Pennec V, Ganne-Carrié N, Garcia-Pagán JC, Mallet M, Larrue H, Dao T, Thabut D, Hernández-Gea V, Nault JC, Bureau C, Allaire M.
PMID: 34018627
Hepatology. 2021 Oct;74(4):2085-2101. doi: 10.1002/hep.31913. Epub 2021 Jul 19.

BACKGROUND AND AIMS: Data about the prognosis of salvage transjugular intrahepatic portosystemic shunt (TIPS) using covered stents for refractory variceal bleeding caused by portal hypertension are scarce. We aimed to assess survival and to identify predictors of mortality in...

Cite
Walter A, Rudler M, Olivas P, et al. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding. Hepatology. 2021;74(4):2085-2101doi: 10.1002/hep.31913.
Walter, A., Rudler, M., Olivas, P., Moga, L., Trépo, E., Robic, M. A., Ollivier-Hourmand, I., Baiges, A., Sutter, O., Bouzbib, C., Peron, J. M., Le Pennec, V., Ganne-Carrié, N., Garcia-Pagán, J. C., Mallet, M., Larrue, H., Dao, T., Thabut, D., Hernández-Gea, V., Nault, J. C., Bureau, C., Allaire, M. (2021). Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding. Hepatology (Baltimore, Md.), 74(4), 2085-2101. https://doi.org/10.1002/hep.31913
Walter, Aurélie, et al. "Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding." Hepatology (Baltimore, Md.) vol. 74,4 (2021): 2085-2101. doi: https://doi.org/10.1002/hep.31913
Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, Ollivier-Hourmand I, Baiges A, Sutter O, Bouzbib C, Peron JM, Le Pennec V, Ganne-Carrié N, Garcia-Pagán JC, Mallet M, Larrue H, Dao T, Thabut D, Hernández-Gea V, Nault JC, Bureau C, Allaire M. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding. Hepatology. 2021 Oct;74(4):2085-2101. doi: 10.1002/hep.31913. Epub 2021 Jul 19. PMID: 34018627.
Copy Download .nbib Format: NLM
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.

Blood cancer journal

Oliva S, Bruinink DHO, Rihova L, D'Agostino M, Pantani L, Capra A, van der Holt B, Troia R, Petrucci MT, Villanova T, Vsianska P, Jugooa R, Brandt-Hagens C, Gilestro M, Offidani M, Ribolla R, Galli M, Hajek R, Gay F, Cavo M, Omedé P, van der Velden VHJ, Boccadoro M, Sonneveld P.
PMID: 34083504
Blood Cancer J. 2021 Jun 03;11(6):106. doi: 10.1038/s41408-021-00498-0.

Minimal residual disease (MRD) by multiparameter flow cytometry (MFC) is the most effective tool to define a deep response in multiple myeloma (MM). We conducted an MRD correlative study of the EMN02/HO95 MM phase III trial in newly diagnosed...

Cite
Oliva S, Bruinink DHO, Rihova L, et al. Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. Blood Cancer J. 2021;11(6):106doi: 10.1038/s41408-021-00498-0.
Oliva, S., Bruinink, D. H. O., Rihova, L., D'Agostino, M., Pantani, L., Capra, A., van der Holt, B., Troia, R., Petrucci, M. T., Villanova, T., Vsianska, P., Jugooa, R., Brandt-Hagens, C., Gilestro, M., Offidani, M., Ribolla, R., Galli, M., Hajek, R., Gay, F., Cavo, M., Omedé, P., van der Velden, V. H. J., Boccadoro, M., & Sonneveld, P. (2021). Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. Blood cancer journal, 11(6), 106. https://doi.org/10.1038/s41408-021-00498-0
Oliva, Stefania, et al. "Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial." Blood cancer journal vol. 11,6 (2021): 106. doi: https://doi.org/10.1038/s41408-021-00498-0
Oliva S, Bruinink DHO, Rihova L, D'Agostino M, Pantani L, Capra A, van der Holt B, Troia R, Petrucci MT, Villanova T, Vsianska P, Jugooa R, Brandt-Hagens C, Gilestro M, Offidani M, Ribolla R, Galli M, Hajek R, Gay F, Cavo M, Omedé P, van der Velden VHJ, Boccadoro M, Sonneveld P. Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. Blood Cancer J. 2021 Jun 03;11(6):106. doi: 10.1038/s41408-021-00498-0. PMID: 34083504; PMCID: PMC8175611.
Copy Download .nbib Format: NLM
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Sonneveld P, Dimopoulos MA, Beksac M, van der Holt B, Aquino S, Ludwig H, Zweegman S, Zander T, Zamagni E, Wester R, Hajek R, Pantani L, Dozza L, Gay F, Cafro A, De Rosa L, Morelli A, Gregersen H, Gulbrandsen N, Cornelisse P, Troia R, Oliva S, van de Velden V, Wu K, Ypma PF, Bos G, Levin MD, Pour L, Driessen C, Broijl A, Croockewit A, Minnema MC, Waage A, Hveding C, van de Donk NWCJ, Offidani M, Palumbo GA, Spencer A, Boccadoro M, Cavo M.
PMID: 34520219
J Clin Oncol. 2021 Nov 10;39(32):3613-3622. doi: 10.1200/JCO.21.01045. Epub 2021 Sep 14.

PURPOSE: To address the role of consolidation treatment for newly diagnosed, transplant eligible patients with multiple myeloma in a controlled clinical trial.PATIENTS AND METHODS: The EMN02/HOVON95 trial compared consolidation treatment with two cycles of bortezomib, lenalidomide, and dexamethasone (VRD)...

Cite
Sonneveld P, Dimopoulos MA, Beksac M, et al. Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. J Clin Oncol. 2021;39(32):3613-3622doi: 10.1200/JCO.21.01045.
Sonneveld, P., Dimopoulos, M. A., Beksac, M., van der Holt, B., Aquino, S., Ludwig, H., Zweegman, S., Zander, T., Zamagni, E., Wester, R., Hajek, R., Pantani, L., Dozza, L., Gay, F., Cafro, A., De Rosa, L., Morelli, A., Gregersen, H., Gulbrandsen, N., Cornelisse, P., Troia, R., Oliva, S., van de Velden, V., Wu, K., Ypma, P. F., Bos, G., Levin, M. D., Pour, L., Driessen, C., Broijl, A., Croockewit, A., Minnema, M. C., Waage, A., Hveding, C., van de Donk, N. W. C. J., Offidani, M., Palumbo, G. A., Spencer, A., Boccadoro, M., & Cavo, M. (2021). Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(32), 3613-3622. https://doi.org/10.1200/JCO.21.01045
Sonneveld, Pieter, et al. "Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 39,32 (2021): 3613-3622. doi: https://doi.org/10.1200/JCO.21.01045
Sonneveld P, Dimopoulos MA, Beksac M, van der Holt B, Aquino S, Ludwig H, Zweegman S, Zander T, Zamagni E, Wester R, Hajek R, Pantani L, Dozza L, Gay F, Cafro A, De Rosa L, Morelli A, Gregersen H, Gulbrandsen N, Cornelisse P, Troia R, Oliva S, van de Velden V, Wu K, Ypma PF, Bos G, Levin MD, Pour L, Driessen C, Broijl A, Croockewit A, Minnema MC, Waage A, Hveding C, van de Donk NWCJ, Offidani M, Palumbo GA, Spencer A, Boccadoro M, Cavo M. Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. J Clin Oncol. 2021 Nov 10;39(32):3613-3622. doi: 10.1200/JCO.21.01045. Epub 2021 Sep 14. PMID: 34520219.
Copy Download .nbib Format: NLM
Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment.

Proteins

Lensink MF, Brysbaert G, Mauri T, Nadzirin N, Velankar S, Chaleil RAG, Clarence T, Bates PA, Kong R, Liu B, Yang G, Liu M, Shi H, Lu X, Chang S, Roy RS, Quadir F, Liu J, Cheng J, Antoniak A, Czaplewski C, Giełdoń A, Kogut M, Lipska AG, Liwo A, Lubecka EA, Maszota-Zieleniak M, Sieradzan AK, Ślusarz R, Wesołowski PA, Zięba K, Del Carpio Muñoz CA, Ichiishi E, Harmalkar A, Gray JJ, Bonvin AMJJ, Ambrosetti F, Vargas Honorato R, Jandova Z, Jiménez-García B, Koukos PI, Van Keulen S, Van Noort CW, Réau M, Roel-Touris J, Kotelnikov S, Padhorny D, Porter KA, Alekseenko A, Ignatov M, Desta I, Ashizawa R, Sun Z, Ghani U, Hashemi N, Vajda S, Kozakov D, Rosell M, Rodríguez-Lumbreras LA, Fernandez-Recio J, Karczynska A, Grudinin S, Yan Y, Li H, Lin P, Huang SY, Christoffer C, Terashi G, Verburgt J, Sarkar D, Aderinwale T, Wang X, Kihara D, Nakamura T, Hanazono Y, Gowthaman R, Guest JD, Yin R, Taherzadeh G, Pierce BG, Barradas-Bautista D, Cao Z, Cavallo L, Oliva R, Sun Y, Zhu S, Shen Y, Park T, Woo H, Yang J, Kwon S, Won J, Seok C, Kiyota Y, Kobayashi S, Harada Y, Takeda-Shitaka M, Kundrotas PJ, Singh A, Vakser IA, Dapkūnas J, Olechnovič K, Venclovas Č, Duan R, Qiu L, Xu X, Zhang S, Zou X, Wodak SJ.
PMID: 34453465
Proteins. 2021 Dec;89(12):1800-1823. doi: 10.1002/prot.26222. Epub 2021 Sep 13.

We present the results for CAPRI Round 50, the fourth joint CASP-CAPRI protein assembly prediction challenge. The Round comprised a total of twelve targets, including six dimers, three trimers, and three higher-order oligomers. Four of these were easy targets,...

Cite
Lensink MF, Brysbaert G, Mauri T, et al. Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment. Proteins. 2021;89(12):1800-1823doi: 10.1002/prot.26222.
Lensink, M. F., Brysbaert, G., Mauri, T., Nadzirin, N., Velankar, S., Chaleil, R. A. G., Clarence, T., Bates, P. A., Kong, R., Liu, B., Yang, G., Liu, M., Shi, H., Lu, X., Chang, S., Roy, R. S., Quadir, F., Liu, J., Cheng, J., Antoniak, A., Czaplewski, C., Giełdoń, A., Kogut, M., Lipska, A. G., Liwo, A., Lubecka, E. A., Maszota-Zieleniak, M., Sieradzan, A. K., Ślusarz, R., Wesołowski, P. A., Zięba, K., Del Carpio Muñoz, C. A., Ichiishi, E., Harmalkar, A., Gray, J. J., Bonvin, A. M. J. J., Ambrosetti, F., Vargas Honorato, R., Jandova, Z., Jiménez-García, B., Koukos, P. I., Van Keulen, S., Van Noort, C. W., Réau, M., Roel-Touris, J., Kotelnikov, S., Padhorny, D., Porter, K. A., Alekseenko, A., Ignatov, M., Desta, I., Ashizawa, R., Sun, Z., Ghani, U., Hashemi, N., Vajda, S., Kozakov, D., Rosell, M., Rodríguez-Lumbreras, L. A., Fernandez-Recio, J., Karczynska, A., Grudinin, S., Yan, Y., Li, H., Lin, P., Huang, S. Y., Christoffer, C., Terashi, G., Verburgt, J., Sarkar, D., Aderinwale, T., Wang, X., Kihara, D., Nakamura, T., Hanazono, Y., Gowthaman, R., Guest, J. D., Yin, R., Taherzadeh, G., Pierce, B. G., Barradas-Bautista, D., Cao, Z., Cavallo, L., Oliva, R., Sun, Y., Zhu, S., Shen, Y., Park, T., Woo, H., Yang, J., Kwon, S., Won, J., Seok, C., Kiyota, Y., Kobayashi, S., Harada, Y., Takeda-Shitaka, M., Kundrotas, P. J., Singh, A., Vakser, I. A., Dapkūnas, J., Olechnovič, K., Venclovas, �. �., Duan, R., Qiu, L., Xu, X., Zhang, S., Zou, X., & Wodak, S. J. (2021). Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment. Proteins, 89(12), 1800-1823. https://doi.org/10.1002/prot.26222
Lensink, Marc F, et al. "Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment." Proteins vol. 89,12 (2021): 1800-1823. doi: https://doi.org/10.1002/prot.26222
Lensink MF, Brysbaert G, Mauri T, Nadzirin N, Velankar S, Chaleil RAG, Clarence T, Bates PA, Kong R, Liu B, Yang G, Liu M, Shi H, Lu X, Chang S, Roy RS, Quadir F, Liu J, Cheng J, Antoniak A, Czaplewski C, Giełdoń A, Kogut M, Lipska AG, Liwo A, Lubecka EA, Maszota-Zieleniak M, Sieradzan AK, Ślusarz R, Wesołowski PA, Zięba K, Del Carpio Muñoz CA, Ichiishi E, Harmalkar A, Gray JJ, Bonvin AMJJ, Ambrosetti F, Vargas Honorato R, Jandova Z, Jiménez-García B, Koukos PI, Van Keulen S, Van Noort CW, Réau M, Roel-Touris J, Kotelnikov S, Padhorny D, Porter KA, Alekseenko A, Ignatov M, Desta I, Ashizawa R, Sun Z, Ghani U, Hashemi N, Vajda S, Kozakov D, Rosell M, Rodríguez-Lumbreras LA, Fernandez-Recio J, Karczynska A, Grudinin S, Yan Y, Li H, Lin P, Huang SY, Christoffer C, Terashi G, Verburgt J, Sarkar D, Aderinwale T, Wang X, Kihara D, Nakamura T, Hanazono Y, Gowthaman R, Guest JD, Yin R, Taherzadeh G, Pierce BG, Barradas-Bautista D, Cao Z, Cavallo L, Oliva R, Sun Y, Zhu S, Shen Y, Park T, Woo H, Yang J, Kwon S, Won J, Seok C, Kiyota Y, Kobayashi S, Harada Y, Takeda-Shitaka M, Kundrotas PJ, Singh A, Vakser IA, Dapkūnas J, Olechnovič K, Venclovas Č, Duan R, Qiu L, Xu X, Zhang S, Zou X, Wodak SJ. Prediction of protein assemblies, the next frontier: The CASP14-CAPRI experiment. Proteins. 2021 Dec;89(12):1800-1823. doi: 10.1002/prot.26222. Epub 2021 Sep 13. PMID: 34453465; PMCID: PMC8616814.
Copy Download .nbib Format: NLM
Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus-Report 2: Diabetic Kidney Disease.

Journal of clinical medicine

Alé-Chilet A, Bernal-Morales C, Barraso M, Hernández T, Oliva C, Vinagre I, Ortega E, Figueras-Roca M, Sala-Puigdollers A, Esquinas C, Gimenez M, Esmatjes E, Adán A, Zarranz-Ventura J.
PMID: 35011940
J Clin Med. 2021 Dec 30;11(1). doi: 10.3390/jcm11010197.

The purpose of this study is to investigate potential associations between optical coherence tomography angiography (OCTA) parameters and diabetic kidney disease (DKD) categories in type 1 diabetes mellitus (T1DM) patients and controls. A complete ocular and systemic examination, including...

Cite
Alé-Chilet A, Bernal-Morales C, Barraso M, et al. Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus-Report 2: Diabetic Kidney Disease. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010197.
Alé-Chilet, A., Bernal-Morales, C., Barraso, M., Hernández, T., Oliva, C., Vinagre, I., Ortega, E., Figueras-Roca, M., Sala-Puigdollers, A., Esquinas, C., Gimenez, M., Esmatjes, E., Adán, A., & Zarranz-Ventura, J. (2021). Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus-Report 2: Diabetic Kidney Disease. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010197
Alé-Chilet, Aníbal, et al. "Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus-Report 2: Diabetic Kidney Disease." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010197
Alé-Chilet A, Bernal-Morales C, Barraso M, Hernández T, Oliva C, Vinagre I, Ortega E, Figueras-Roca M, Sala-Puigdollers A, Esquinas C, Gimenez M, Esmatjes E, Adán A, Zarranz-Ventura J. Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus-Report 2: Diabetic Kidney Disease. J Clin Med. 2021 Dec 30;11(1). doi: 10.3390/jcm11010197. PMID: 35011940; PMCID: PMC8745787.
Copy Download .nbib Format: NLM
Letter to Editor about 'Kiss goodbye to the "kissing knees": no association between frontal plane inward knee motion and risk of future non-contact ACL injury in elite female athletes'.

Sports biomechanics

Russo L, Padulo J, Oliva F, Maffulli N.
PMID: 34455926
Sports Biomech. 2021 Aug 29;1-3. doi: 10.1080/14763141.2021.1968024. Epub 2021 Aug 29.

No abstract available.

Cite
Russo L, Padulo J, Oliva F, et al. Letter to Editor about 'Kiss goodbye to the "kissing knees": no association between frontal plane inward knee motion and risk of future non-contact ACL injury in elite female athletes'. Sports Biomech. 2021;1-3doi: 10.1080/14763141.2021.1968024.
Russo, L., Padulo, J., Oliva, F., & Maffulli, N. (2021). Letter to Editor about 'Kiss goodbye to the "kissing knees": no association between frontal plane inward knee motion and risk of future non-contact ACL injury in elite female athletes'. Sports biomechanics, 1-3. https://doi.org/10.1080/14763141.2021.1968024
Russo, Luca, et al. "Letter to Editor about 'Kiss goodbye to the "kissing knees": no association between frontal plane inward knee motion and risk of future non-contact ACL injury in elite female athletes'." Sports biomechanics vol. (2021): 1-3. doi: https://doi.org/10.1080/14763141.2021.1968024
Russo L, Padulo J, Oliva F, Maffulli N. Letter to Editor about 'Kiss goodbye to the "kissing knees": no association between frontal plane inward knee motion and risk of future non-contact ACL injury in elite female athletes'. Sports Biomech. 2021 Aug 29;1-3. doi: 10.1080/14763141.2021.1968024. Epub 2021 Aug 29. PMID: 34455926.
Copy Download .nbib Format: NLM
Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline.

Journal of pediatric gastroenterology and nutrition

Lightdale JR, Walsh CM, Fishman DS, Furlano RI, Mamula P, Gillett PM, Narula P, Hojsak I, Oliva S, Homan M, Riley MR, Huynh HQ, Rosh JR, Jacobson K, Tavares M, Leibowitz IH, Utterson EC, Croft NM, Mack DR, Brill H, Liu QY, Bontems P, Lerner DG, Amil-Dias J, Kramer RE, Otley AR, Ambartsumyan L, Connan V, McCreath GA, Thomson MA.
PMID: 34402488
J Pediatr Gastroenterol Nutr. 2021 Aug 16; doi: 10.1097/MPG.0000000000003266. Epub 2021 Aug 16.

INTRODUCTION: High quality procedure reports are a cornerstone of high quality pediatric endoscopy as they ensure the clear communication of procedural events and outcomes, guide patient care and facilitate continuous quality improvement. The aim of this document is to...

Cite
Lightdale JR, Walsh CM, Fishman DS, et al. Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline. J Pediatr Gastroenterol Nutr. 2021;doi: 10.1097/MPG.0000000000003266.
Lightdale, J. R., Walsh, C. M., Fishman, D. S., Furlano, R. I., Mamula, P., Gillett, P. M., Narula, P., Hojsak, I., Oliva, S., Homan, M., Riley, M. R., Huynh, H. Q., Rosh, J. R., Jacobson, K., Tavares, M., Leibowitz, I. H., Utterson, E. C., Croft, N. M., Mack, D. R., Brill, H., Liu, Q. Y., Bontems, P., Lerner, D. G., Amil-Dias, J., Kramer, R. E., Otley, A. R., Ambartsumyan, L., Connan, V., McCreath, G. A., Thomson, M. A. (2021). Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline. Journal of pediatric gastroenterology and nutrition, . https://doi.org/10.1097/MPG.0000000000003266
Lightdale, Jenifer R, et al. "Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline." Journal of pediatric gastroenterology and nutrition vol. (2021). doi: https://doi.org/10.1097/MPG.0000000000003266
Lightdale JR, Walsh CM, Fishman DS, Furlano RI, Mamula P, Gillett PM, Narula P, Hojsak I, Oliva S, Homan M, Riley MR, Huynh HQ, Rosh JR, Jacobson K, Tavares M, Leibowitz IH, Utterson EC, Croft NM, Mack DR, Brill H, Liu QY, Bontems P, Lerner DG, Amil-Dias J, Kramer RE, Otley AR, Ambartsumyan L, Connan V, McCreath GA, Thomson MA. Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline. J Pediatr Gastroenterol Nutr. 2021 Aug 16; doi: 10.1097/MPG.0000000000003266. Epub 2021 Aug 16. PMID: 34402488.
Copy Download .nbib Format: NLM
Null effects of boot camps and short-format training for PhD students in life sciences.

Feldon DF, Peugh J, Roksa J, Maahs-Fladung C, Jeong S, Shenoy A, Oliva M.
UIID-AD: 4801
2017;9854-9858. doi: 10.1073/pnas.1705783114.

Many PhD programs incorporate boot camps and summer bridge programs to accelerate the development of doctoral students’ research skills and acculturation into their respective disciplines. These brief, high-intensity experiences span no more than several weeks and are typically designed...

Cite
Feldon DF, Peugh J, Roksa J, et al. Null effects of boot camps and short-format training for PhD students in life sciences. 2017;9854-9858doi: 10.1073/pnas.1705783114.
Feldon, D. F., Peugh, J., Roksa, J., Maahs-Fladung, C., Jeong, S., Shenoy, A., & Oliva, M. (2017). Null effects of boot camps and short-format training for PhD students in life sciences. 9854-9858. https://doi.org/10.1073/pnas.1705783114
Feldon, D F, et al. "Null effects of boot camps and short-format training for PhD students in life sciences." vol. (2017): 9854-9858. doi: https://doi.org/10.1073/pnas.1705783114
Feldon DF, Peugh J, Roksa J, Maahs-Fladung C, Jeong S, Shenoy A, Oliva M. Null effects of boot camps and short-format training for PhD students in life sciences. 2017;9854-9858. doi: 10.1073/pnas.1705783114. UIID-AD: 4801.
Copy Download .nbib Format: NLM
Showing 913 to 922 of 922 entries